1. CMET-22. INTRATHECAL (IT) TRAZTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY. (5th November 2018) Authors: Kumthekar, Priya; Gradishar, William; Lin, Nancy; Pentsova, Elena; Groves, Morris; Jeyapalan, Suriya; Melisko, Michelle; Grimm, Sean; B. Lassman, Andrew; Raizer, Jeffrey Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ATIM-16. PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM). (5th November 2018) Authors: Khasraw, Mustafa; Weller, Michael; Estelles, David Lorente; Kolibaba, Kathryn; Lee, Chee; Gedye, Craig; De La Fuente, Macarena; Vicente, David; Reardon, David; Ojalvo, Laureen; Helwig, Christoph; Gourmelon, Carole; Groves, Morris Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS. (5th November 2018) Authors: Puduvalli, Vinay; Wu, Jing; Yuan, Ying; Armstrong, Terri; Wu, Jimin; Giglio, Pierre; Xu, Jihong; Colman, Howard; Walbert, Tobias; Raizer, Jeffrey; Groves, Morris; Iwamoto, Fabio; Tran, David; Avgeropoulos, Nicholas; Paleologos, Nina; Fink, Karen; Peereboom, David; Chamberlain, Marc; Merrell, Ryan... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192). (5th November 2018) Authors: Zadeh, Gelareh; Lang, Frederick; Daras, Mariza; Cloughesy, Timothy; Colman, Howard; Ong, Shirley; Ramakrishna, Rohan; Vogelbaum, Michael; Groves, Morris; Nassiri, Farshad; Frederick, L Sue; Gammon, Karen; Fulling, Sheila; Rowland, Kari Anne; Mitchell, Erin; Ewald, Brett; Tufaro, Frank; Peterkin, ... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PATH-22. THE DEVELOPMENT OF A NEW ASSAY TO MEASURE 2-HYDROXYGLUTARATE (2-hg) ENANTIOMER LEVELS AND THE UTILITY OF 2-hg AS A BIOMARKER FOR MANAGEMENT OF IDH MUTANT GLIOMAS. (5th November 2018) Authors: Strain, Shinji; Groves, Morris; Emmett, Mark Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. ACTR-33. INFIGRATINIB (BGJ398) IN PATIENTS WITH RECURRENT GLIOMAS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) ALTERATIONS: A MULTICENTER PHASE II STUDY. (11th November 2019) Authors: Lassman, Andrew; Sepúlveda-Sánchez, Juan; Cloughesy, Timothy; Gil-Gil, Juan; Puduvalli, Vinay; Raizer, Jeffrey; De Vos, Filip; Wen, Patrick; Butowski, Nicholas; Clement, Paul; Groves, Morris; Belda-Iniesta, Cristobal; Steward, Keith; Rowsey, Steven; Ye, Yining; Roth, Patrick Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. ATIM-33. INTERIM RESULTS OF A PHASE II MULTI-CENTER STUDY OF ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192). (11th November 2019) Authors: Aiken, Robert; Chen, Clark; Cloughesy, Timothy; Colman, Howard; Daras, Mariza; Groves, Morris; Khagi, Simon; Kumthekar, Priya; Lang, Frederick; Nassiri, Farshad; Ong, Shirley; Ramakrishna, Rohan; Sonabend, Adam; Vogelbaum, Michael; Zadeh, Gelareh; Agensky, Laura; Bidwell, Carin; Watkins, Barry; T... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CMET-19. QUESTIONING THE PARADIGM: DO CSF CYTOLOGY AND MRI SCANNING IDENTIFY THE SAME DISEASE IN PATIENTS WITH NEOPLASTIC MENINGITIS (NM) – DATA FROM AN INTERNATIONAL NM REGISTRY AND A META-ANALYSIS. (11th November 2019) Authors: Messner, Christopher; Groves, Morris; Hofer, Silvia; Roberge, David; Aregawi, Dawit; Jeyapalan, Suriya; Rudà, Roberta; Glantz, Michael Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. LPTO-09. INTRATHECAL TOPOTECAN FOR LEPTOMENINGEAL METASTASIS IN SOLID TUMORS: THE MD ANDERSON EXPERIENCE. (12th August 2019) Authors: Sinicrope, Kaylyn D; Barata, Pedro; Walker, Julie; Tremont-Lukats, Ivo W; Groves, Morris; Loghin, Monica; Seligman, Christa; Ferguson, Sherise; Weathers, Shiao-Pei; Penas-Prado, Marta; Kamiya-Matsuoka, Carlos; Harrison, Rebecca; Tummala, Sudhakar; Trevino, Christopher R; Peinado, Shanta; Murthy, ... Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. LPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL DISEASE (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL RECEPTOR-2 POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY. (12th August 2019) Authors: Kumthekar, Priya; Lassman, Andrew B; Lin, Nancy; Grimm, Sean; Gradishar, William; Pentsova, Elena; Jeyapalan, Suriya; Groves, Morris; Melisko, Melissa; Raizer, Jeffrey Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗